• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The effect of 5-aminosalicylate and para-aminosalicylate on the synthesis of prostaglandin E2 and leukotriene B4 in isolated colonic mucosal cells.

作者信息

Schmidt C, Fels T, Baumeister B, Vetter H

机构信息

Medical Poliklinik, University of Bonn, Germany.

出版信息

Curr Med Res Opin. 1996;13(7):417-25. doi: 10.1185/03007999609111561.

DOI:10.1185/03007999609111561
PMID:8862941
Abstract

The effect of 5-aminosalicylate (5-ASA) and para-aminosalicylate (PAS) on the synthesis of prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) was studied in 24 healthy volunteers. Both drugs are successfully used in the treatment of chronic inflammatory bowel disease, but the biochemical pathway of their anti-inflammatory action is still unknown. Biopsies were taken from the descending colon and were isolated biochemically. 5-ASA, PAS and a control were added to the suspension of isolated colonic mucosal cells and incubated over 0-45 min. Both 5-ASA and PAS did not alter the PGE2 production but, compared with PAS and the control, 5-ASA decreased the LTB4 synthesis in a dose-related fashion. As a result, the LTB4/PGE2 ratio was significantly diminished by 10(-4) mol/l 5-ASA. These findings are consistent with those of other authors, indicating that 5-ASA, at least in part, modulates the colonic eicosanoid synthesis. In contrast, PAS did not influence the mucosal production of PGE2 and LTB4 and therefore must exert some other biochemical action in order to explain its therapeutic effects in the treatment of Crohn's disease or ulcerative colitis.

摘要

相似文献

1
The effect of 5-aminosalicylate and para-aminosalicylate on the synthesis of prostaglandin E2 and leukotriene B4 in isolated colonic mucosal cells.
Curr Med Res Opin. 1996;13(7):417-25. doi: 10.1185/03007999609111561.
2
Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.炎症性肠病中的花生四烯酸代谢与细胞内钙浓度
Eur J Gastroenterol Hepatol. 1995 Sep;7(9):865-9.
3
Increased prostaglandin E2 and leukotriene B4 synthesis in isolated colonic mucosal cells in inflammatory bowel disease. a preliminary report.炎症性肠病中分离的结肠黏膜细胞中前列腺素E2和白三烯B4合成增加。初步报告。
J Clin Gastroenterol. 1996 Mar;22(2):117-20. doi: 10.1097/00004836-199603000-00009.
4
Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
Eur J Gastroenterol Hepatol. 1995 Mar;7(3):221-6.
5
Effect of drugs on colonic eicosanoid accumulation in active ulcerative colitis.
Scand J Gastroenterol. 1992 Nov;27(11):968-72. doi: 10.3109/00365529209000172.
6
Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.阿司匹林对癌症患者人结肠黏膜中前列腺素E2和白三烯B4生成的影响。
Clin Cancer Res. 1997 Feb;3(2):209-13.
7
Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.克罗恩病中的白三烯:柳氮磺胺吡啶和5-氨基水杨酸的作用
Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:339-43.
8
Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.慢性炎症性肠病中前列腺素E2和白三烯B4合成的改变
Hepatogastroenterology. 1996 Nov-Dec;43(12):1508-12.
9
Possible mode of action of 5-aminosalicylic acid.5-氨基水杨酸可能的作用方式。
Dig Dis Sci. 1987 Dec;32(12 Suppl):51S-56S. doi: 10.1007/BF01312464.
10
Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine, and 5-aminosalicylic acid.
Aliment Pharmacol Ther. 1988 Jun;2(3):203-11. doi: 10.1111/j.1365-2036.1988.tb00689.x.

引用本文的文献

1
Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques.抗生素和抗炎疗法可短暂减轻急性感染SIV的猪尾猕猴的炎症和高凝状态。
PLoS Pathog. 2016 Jan 14;12(1):e1005384. doi: 10.1371/journal.ppat.1005384. eCollection 2016 Jan.
2
Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease.改良释放型美沙拉嗪在溃疡性结肠炎和克罗恩病治疗中的作用最新进展
Clin Exp Gastroenterol. 2009;2:139-47. doi: 10.2147/ceg.s6145. Epub 2009 Dec 8.
3
Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.
改善溃疡性结肠炎中氨基水杨酸盐的给药方式:对患者预后的影响。
Drugs. 2008;68(8):1089-103. doi: 10.2165/00003495-200868080-00006.
4
Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.缓释美沙拉嗪:对其在溃疡性结肠炎和克罗恩病中的治疗潜力的综述
Drugs. 2000 Apr;59(4):929-56. doi: 10.2165/00003495-200059040-00016.
5
Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn's disease.口服缓释美沙拉嗪:其在溃疡性结肠炎和克罗恩病中的应用综述
Drugs. 1999 Mar;57(3):383-408. doi: 10.2165/00003495-199957030-00013.